Cullinan Associates’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$599K	Hold	8,675	–	–	0.04%	158
2025 Q1	$602K	Hold	8,675	–	–	0.04%	153
2024 Q4	$746K	Sell	8,675 -325	-4%	-$28K	0.05%	148
2024 Q3	$1.06M	Sell	9,000 -400	-4%	-$46.9K	0.06%	135
2024 Q2	$1.34M	Sell	9,400 -4,000	-30%	-$571K	0.08%	128
2024 Q1	$1.72M	Hold	13,400	–	–	0.1%	123
2023 Q4	$1.39M	Hold	13,400	–	–	0.08%	133
2023 Q3	$1.22M	Hold	13,400	–	–	0.07%	137
2023 Q2	$1.08M	Hold	13,400	–	–	0.06%	151
2023 Q1	$1.07M	Sell	13,400 -2,116	-14%	-$168K	0.06%	153
2022 Q4	$1.05M	Buy	15,516 +2,116	+16%	+$143K	0.06%	155
2022 Q3	$668K	Hold	13,400	–	–	0.04%	162
2022 Q2	$747K	Hold	13,400	–	–	0.05%	153
2022 Q1	$744K	Hold	13,400	–	–	0.04%	160
2021 Q4	$750K	Hold	13,400	–	–	0.04%	158
2021 Q3	$643K	Hold	13,400	–	–	0.04%	167
2021 Q2	$561K	Hold	13,400	–	–	0.03%	168
2021 Q1	$452K	Hold	13,400	–	–	0.03%	163
2020 Q4	$468K	Buy	13,400 +5,000	+60%	+$175K	0.03%	151
2020 Q3	$292K	Hold	8,400	–	–	0.02%	160
2020 Q2	$275K	Hold	8,400	–	–	0.02%	163
2020 Q1	$253K	Hold	8,400	–	–	0.02%	156
2019 Q4	$243K	Hold	8,400	–	–	0.02%	170
2019 Q3	$217K	Hold	8,400	–	–	0.02%	171
2019 Q2	$214K	Hold	8,400	–	–	0.02%	176
2019 Q1	$220K	Sell	8,400 -600	-7%	-$15.7K	0.02%	174
2018 Q4	$207K	Hold	9,000	–	–	0.02%	178
2018 Q3	$212K	Hold	9,000	–	–	0.02%	175
2018 Q2	$208K	Hold	9,000	–	–	0.02%	176
2018 Q1	$222K	Hold	9,000	–	–	0.02%	176
2017 Q4	$242K	Hold	9,000	–	–	0.02%	174
2017 Q3	$217K	Buy	+9,000	New	+$217K	0.02%	183
2016 Q3	–	Sell	-9,000	Closed	-$242K	–	204
2016 Q2	$242K	Hold	9,000	–	–	0.02%	189
2016 Q1	$244K	Buy	+9,000	New	+$244K	0.02%	185